| |
| |
|
| Insider
Information: |
Peacock Jonathan M |
| Relationship: |
Director |
| City: |
Thousand Oaks |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
446,071 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$35,072,079 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
446,071 |
|
|
| Total
Value |
$35,072,079 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amgen Inc |
AMGN |
EVP & CFO |
2013-10-28 |
94,414 |
2010-10-28 |
0 |
Premium* |
|
|
Kite Pharma, Inc. |
KITE |
Director |
2017-10-03 |
0 |
2014-06-25 |
0 |
Premium* |
|
|
Bellerophon Therapeutics Inc |
BLPH |
|
2021-03-31 |
157,033 |
|
0 |
Premium* |
|
|
Avantor, Inc. |
AVTR |
Director |
2024-05-09 |
194,624 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BLPH |
Bellerophon Therapeutics ... |
President and CEOOfficer |
• • – |
2015-02-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
67 |
|
- |
|
| AVTR |
Avantor, Inc. |
Director |
– • – |
2019-05-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,858 |
|
- |
|
| AMGN |
Amgen Inc |
CFO |
• – – |
2010-10-28 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
0 |
- |
|
| AMGN |
Amgen Inc |
CFO |
• – – |
2011-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
15,800 |
115,800 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• – – |
2012-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,654 |
114,027 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2013-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,477 |
109,950 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
President and CEO |
• • – |
2016-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
165,975 |
217,702 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2016-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,950 |
67,964 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2016-11-29 |
4 |
B |
$0.00 |
$0 |
D/D |
285,715 |
508,417 |
2.31 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,410 |
70,374 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2017-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
57,972 |
566,389 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-09-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
635 |
69,739 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2017-09-29 |
4 |
B |
$0.00 |
$0 |
D/D |
248,962 |
815,351 |
2.31 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-10-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,807) |
0 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
99,010 |
914,361 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2019-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
227,273 |
1,141,634 |
0 |
- |
|
| AVTR |
Avantor, Inc. |
Director |
– • – |
2019-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
14,286 |
24,144 |
0 |
- |
|
| AVTR |
Avantor, Inc. |
Director |
– • – |
2019-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
117,857 |
142,001 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2020-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
350,000 |
2,225,920 |
0 |
- |
|
| AVTR |
Avantor, Inc. |
Director |
– • – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
11,319 |
161,195 |
0 |
- |
|
| AVTR |
Avantor, Inc. |
Director |
– • – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
7,236 |
168,431 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
|
– • – |
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
15,308 |
157,033 |
0 |
- |
|
| AVTR |
Avantor, Inc. |
Director |
– • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,215 |
169,646 |
0 |
- |
|
| AVTR |
Avantor, Inc. |
Director |
– • – |
2022-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
6,693 |
176,339 |
0 |
- |
|
| AVTR |
Avantor, Inc. |
Director |
– • – |
2023-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
9,808 |
186,147 |
0 |
- |
|
40 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
